I

Instadose Pharma Corp
OTC:INSD

Watchlist Manager
Instadose Pharma Corp
OTC:INSD
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 53.2k USD

Intrinsic Value

INSD doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of INSD.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INSD Intrinsic Value
Not Available
I
Base Case Scenario
Compare INSD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INSD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Instadose Pharma Corp

Balance Sheet Decomposition
Instadose Pharma Corp

Current Assets 89.2k
Cash & Short-Term Investments 5.3k
Other Current Assets 83.9k
Non-Current Assets 45.9m
Long-Term Investments 93.4k
PP&E 4m
Intangibles 40m
Other Non-Current Assets 1.7m
Current Liabilities 10.2m
Accounts Payable 5m
Accrued Liabilities 4.3m
Short-Term Debt 51.8k
Other Current Liabilities 800.1k
Non-Current Liabilities 82k
Other Non-Current Liabilities 82k
Efficiency

Free Cash Flow Analysis
Instadose Pharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Instadose Pharma Corp

Revenue
0 USD
Operating Expenses
-1.6m USD
Operating Income
-1.6m USD
Other Expenses
-27.1k USD
Net Income
-1.6m USD
Fundamental Scores

INSD Profitability Score
Profitability Due Diligence

Instadose Pharma Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
ROE is Increasing
Declining ROIC
56/100
Profitability
Score

Instadose Pharma Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

INSD Solvency Score
Solvency Due Diligence

Instadose Pharma Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Positive Net Debt
61/100
Solvency
Score

Instadose Pharma Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INSD Price Targets Summary
Instadose Pharma Corp

There are no price targets for INSD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Instadose Pharma Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for INSD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y